Chinese Pla General Hospital
Clinical trials sponsored by Chinese Pla General Hospital, explained in plain language.
-
New stem cell combo may boost transplant success for rare blood disorder
Disease control ENROLLING_BY_INVITATIONThis early-phase trial tests whether adding specially grown umbilical cord stem cells to a standard bone marrow transplant can help people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. About 40 participants aged 6 to 60 will …
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 30, 2026 21:23 UTC
-
New vaccine combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a custom-made vaccine (KRAS-EphA2-CAR-DC) combined with two immunotherapy drugs (anti-PD-1 and anti-CTLA4) in 9 adults with advanced solid tumors that have specific genetic markers (EphA2 and KRAS mutations). The goal is to see if the treatment is saf…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 29, 2026 14:18 UTC
-
New lung cell discovery may revolutionize pneumonia diagnosis
Diagnosis OngoingThis study looks at whether special cells, called 'showering cells,' found in lung fluid can help doctors diagnose aspiration pneumonia (a lung infection caused by inhaling food or liquid). Researchers will compare 94 adults with and without the condition to see how accurate this…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated May 18, 2026 12:04 UTC
-
New breathing monitor aims to prevent low oxygen after surgery
Symptom relief ENROLLING_BY_INVITATIONThis study tests if a special breathing monitor (IPI) can help doctors decide when to safely remove a breathing tube after surgery. About 632 adults having abdominal surgery will be randomly assigned to either IPI-guided or standard care. The goal is to see if the monitor reduces…
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated May 29, 2026 14:18 UTC
-
New migraine drug tested on 3,000 patients in Real-World setting
Symptom relief OngoingThis study looks at how well Rimegepant works for treating migraine attacks in everyday life. About 3,000 adults with migraines in China will take the drug as needed and report their pain levels, satisfaction, and quality of life over a year. The goal is to see if Rimegepant prov…
Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated May 26, 2026 12:05 UTC
-
New tool could spot hidden diabetes risk in psoriasis patients
Knowledge-focused OngoingThis study looks at medical records from over 1,200 adults with psoriasis to find who is most likely to develop insulin resistance, a condition that can lead to diabetes. Researchers will use machine learning to build a simple tool that helps doctors estimate this risk. No new tr…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated May 27, 2026 12:03 UTC